Abhik Bhattacharya
Overview
Explore the profile of Abhik Bhattacharya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hong S, Dalal R, Kuhn K, Stahly A, Scott F, Scott F, et al.
Am J Gastroenterol
. 2025 Jan;
PMID: 39760386
Introduction: Spondyloarthritis (SpA), the most common extraintestinal manifestation of inflammatory bowel disease (IBD), is reported in up to 39% of patients with IBD. Despite this high prevalence, risk factors of...
2.
Ermann J, Hong S, Stahly A, Dalal R, Malik F, Scott F, et al.
Arthritis Care Res (Hoboken)
. 2025 Jan;
PMID: 39748206
Objective: Spondyloarthritis (SpA) is the most common extraintestinal manifestation of inflammatory bowel disease (IBD). The application of screening tools to detect SpA in patients with IBD may lead to earlier...
3.
Falloon K, Dossaji Z, Mude P, Abushamma S, Ananthakrishnan A, Barnes E, et al.
Inflamm Bowel Dis
. 2024 Jun;
31(3):812-842.
PMID: 38836521
Background: Inflammatory bowel disease (IBD)-associated peripheral spondyloarthritis (pSpA) decreases quality of life and remains poorly understood. Given the prevalence of this condition and its negative impact, it is surprising that...
4.
Gagrat Z, Krockenberger M, Bhattacharya A, Gagrat B, Leduc C, Matter M, et al.
Cancer Prev Res (Phila)
. 2024 Jan;
17(3):119-126.
PMID: 38224564
Prevention Relevance: This study highlights performance of the next-generation mt-sDNA test, which exhibits high sensitivity and specificity for detecting colorectal cancer and APLs. This noninvasive option has potential to increase...
5.
Gottlieb Z, Dolinger M, Kayal M, Rao B, Bhattacharya A, Dubinsky M, et al.
Dig Dis Sci
. 2022 May;
67(8):3557-3561.
PMID: 35579797
No abstract available.
6.
Falloon K, Cohen B, Ananthakrishnan A, Barnes E, Bhattacharya A, Colombel J, et al.
Aliment Pharmacol Ther
. 2022 Mar;
55(9):1179-1191.
PMID: 35277863
Background And Aims: Extra-intestinal manifestations (EIMs) are a common complication of inflammatory bowel diseases (IBD), affecting up to half of the patients. Despite their high prevalence, information on standardised definitions,...
7.
Guillo L, Abreu M, Panaccione R, Sandborn W, Azevedo V, Gensler L, et al.
Lancet Gastroenterol Hepatol
. 2022 Jan;
7(3):254-261.
PMID: 35051383
Extraintestinal manifestations occur frequently in patients with inflammatory bowel disease (IBD) and remain a diagnostic and therapeutic challenge. The aim of the Endpoints for Extraintestinal Manifestations in Inflammatory Bowel Disease...
8.
Bhattacharya A, Travis D, Osterman M, Lewis J, Rao B, Lee H, et al.
J Clin Gastroenterol
. 2021 Dec;
57(1):66-73.
PMID: 34907922
Background: It is uncertain if higher infliximab trough levels (TLs) confer a greater risk of infectious/noninfectious complications (IC/NIC). We aimed to assess the risk of IC and NIC in patients...
9.
Kayal M, Rao B, Bhattacharya A, Ungaro R
Dig Dis Sci
. 2021 Aug;
66(10):3300-3302.
PMID: 34415452
No abstract available.
10.
Chalasani N, Porter K, Bhattacharya A, Book A, Neis B, Xiong K, et al.
Clin Gastroenterol Hepatol
. 2021 Aug;
20(1):173-182.e7.
PMID: 34391922
Background & Aims: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Although biannual ultrasound surveillance with or without α-fetoprotein (AFP) testing is recommended for at-risk patients, sensitivity...